Chengdu, China · Founded 2019 · In IPO Registration
Developer of innovative biopharmaceutical technologies designed to accelerate the discovery and commercialization of new drugs. Zenitar Biomedical is based in Chengdu, China and was founded in 2019. Its last reported valuation was $479 million in Nov 2025. It has raised $165 million.
Last reported valuation
$479.0M
Oct 2026
Priced at
—
Total raised
$165.1M
Last round
—
Cap table — not yet on record
Zenitar Biomedical's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Zenitar Biomedical with a free account
·The complete investor list: 27 names
·Watch Zenitar Biomedical: the Monday email on marks, rounds and moves
